We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Brain Cancer

Journal Scan / Research · May 31, 2021

Veliparib + RT + TMZ in Patients With Unmethylated MGMT Glioblastoma



Additional Info

A Randomized Phase II Trial of Veliparib, Radiotherapy and Temozolomide in Patients With Unmethylated MGMT Glioblastoma: The VERTU Study
Neuro-oncology 2021 May 13;[EPub Ahead of Print], HW Sim, KL McDonald, Z Lwin, EH Barnes, M Rosenthal, MC Foote, ES Koh, M Back, H Wheeler, EP Sulman, ME Buckland, L Fisher, R Leonard, M Hall, DM Ashley, S Yip, J Simes, M Khasraw

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading